hyperactivity
Pharmacological stimulation of 5-HT(2A) receptors enhances the conditioned hyperlocomotion, while activation of 5-HT(2C) receptors decreases both the response to acute nicotine and conditioned hyperactivity.
Pharmacological stimulation of 5-HT(2A) receptors enhances the conditioned hyperlocomotion, while activation of <span class="gene" id="19347958-11-112-119">5-HT(2C</span>) receptors decreases both the response to acute nicotine and conditioned <span class="disease" id="19347958-11-193-206">hyperactivity</span>.